Colgate-Palmolive and Klox Technologies Enter Into Agreements for Oral Health
Colgate Palmolive and Klox Technologies Enter Into Agreements for Oral Health NEW YORK and LAVAL, Quebec, Feb. 08, 2016 (GLOBE NEWSWIRE) — Colgate Palmolive Company ("Colgate") and Klox Technologies Inc. ("KLOX") have entered into agreements to globally commercialize and further
Colgate-Palmolive and Klox Technologies Enter Into Agreements for Oral Health
NEW YORK and LAVAL, Quebec, Feb. 08, 2016 (GLOBE NEWSWIRE) — Colgate-Palmolive Company (“Colgate”) and Klox Technologies Inc. (“KLOX”) have entered into agreements to globally commercialize and further develop KLOX’s human Oral Health technology platform. The agreements include a worldwide license to commercialize KLOX’s proprietary Biophotonic technology in the field of human Oral Health and an equity investment in KLOX by Colgate.
Dr. Lise Hébert, President and CEO of KLOX, stated: “We are extremely pleased to have Colgate-Palmolive, the leader in Oral Care, with activities in over 200 countries and territories be our global partner for our Oral Health platform. These agreements once again recognize the breadth of our technology platform. Furthermore, these agreements validate the value creation strategy we have adopted by partnering large potential indications with first in class partners, while building a specialized salesforce for products within Wound Care.”
Suzan Harrison, President of Global Oral Care of Colgate, stated: “We are very pleased to have KLOX as a partner in the development of this exciting and new technology platform for the benefit of Oral Health.”
# # #
